Lomustine

Key takeaways

Lomustine belongs to chemistry; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Lomustine to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Lomustine from memory before moving on to harder problems.

Reference excerpt

Lomustine (INN; abbreviated as CCNU; original brand name CeeNU, now marketed as Gleostine) is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as streptozotocin. It is a highly lipid-soluble drug, thus it crosses the blood–brain barrier. This property makes it ideal for treating brain tumors, which is its primary use, although it is also used to treat Hodgkin lymphoma as a second-line option. It has also been used in veterinary practice as a treatment for cancers in cats and dogs. Lomustine is a bifunctional alkylating agent, alkylates both DNA and RNA, has the ability to created interstrand cross-links (ICLs) in DNA. As with other nitrosoureas, it may also inhibit several key enzymatic processes by carbamoylation of amino acids in proteins. Lomustine is cell-cycle nonspecific.

Medical uses

Chemotherapy in human medicine Lomustine is an alkylating chemotherapy drug that is indicated by the FDA for the treatment of patients with brain tumors (primary and metastatic), following any necessary surgery and radiation, as well as for treatment of progressive Hodgkin's lymphoma. Lomustine is approved for the treatment of brain tumors, breast cancer, lung cancer, Hodgkin's lymphoma, and melanoma by Health Canada. Lomustine is also used as an anti-cancer drug in several European countries, including the United Kingdom.

Pregnant patients While current data is only based on animal studies, there is reason to believe that lomustine use during pregnancy can cause harm to a fetus, potentially leading to miscarriages or birth defects. Patients are advised not to take lomustine while pregnant. Patients hoping to conceive should be aware that lumostine may have the capacity to reduce fertility. Patients are advised to use birth control with partners while taking lomustine due to the potential for fetal harm.

Breastfeeding patients No research currently exists on the effects of lomustine and its metabolites on breastfed infants. However, patients on Lomustine are advised not to breastfeed during the course of treatment due to the potential for serious adverse reactions to the drug.

Pediatric patients There is insufficient clinical data surrounding the use of lomustine in pediatric populations. Current protocols use the same dosing and treatment protocols for pediatric patents as adult patients.

Geriatric patients While there are no clinical studies on lomustine use in the 65+ age group, clinicians are recommended to exercise caution in prescribing this drug to geriatric patients. Lomustine causes high levels of organ toxicity, which must be taken into account when determining dosing for elderly patients.

Chemotherapy in veterinary medicine Lomustine is used as an "off-label" veterinary treatment for cancers in cats and dogs. Clinical trials have demonstrated the drug's success in treating progressive lymphomas, mast cell tumors, and brain cancers. The chemotherapy has also been used to treat sarcomas and spinal cord tumors in these animals. Lomustine may be administered orally or by injection in cats and dogs. This chemotherapy has been observed to have a variety of side effects in animals, paralleling those in humans, including but not limited to bone marrow immunosuppression, gastrointestinal issues, and hepatotoxicity.

Administration Lomustine is available in 5 mg (yellow capsule), 10 mg (white capsule), 40 mg (white & green capsule), and 100 mg (green capsule) gel capsules, referred to as Gleostine. Lomustine dosing is calculated based on body surface area. One dose of the drug is administered orally every 6 weeks, generally at a dosage of 130 mg/m2 for all patients. The dose may be lowered based on the patients blood counts and immune strength, but is still administered every 6 weeks. Lomustine must be taken on an empty stomach of at least two hours. Lomustine is highly toxic; as such, only one dose is dispensed at a time in order to lower overdose risk. Due to the cytotoxic nature of lomustine, the drug must be dosed, administered, and disposed of with special precautions including wearing gloves to prevent dermal exposure.

Side effects Lumostine causes a variety of side effects including gastrointestinal, ocular, neurologic, and other disorders. Certain side effects from lumostine require immediate medical attention. These commonly include, but are not limited to, bleeding gums, chest pain, shortness of breath, sores or white spots in the mouth, fever, edema of the legs, abnormal bleeding or bruising, tar-like stools, blood in the urine or stool, and extreme fatigue. Other side effects that may occur as the body adjusts to this drug do not require medical attention. These include, but are not limited to, hair loss, inflammation of the mouth, trouble with speaking, blurred vision, and shakiness.

Safety

Toxicities Lomustine use is linked to a variety of organ toxicities hepatotoxicity, nephrotoxicity, and pulmonary toxicity. Hepatotoxicity occurs due to increased levels of liver transaminases, alkaline phosphatase, and bilirubin with lumostine use. Liver enzymes and function should be monitored during use and dose should be adjusted based on toxicity levels. Lomustine causes progressive kidney shrinkage and failure with long-term use. Renal enzymes and function should be monitored during use and dose should be adjusted based on toxicity levels. Lomustine can cause or worsen pulmonary infiltrates and fibrosis in patients. Pulmonary toxicity generally occurs after at least 6 months of treatment with lumostine. Lung function should be monitored via Forced Vital Capacity (FVC) or Carbon Monoxide Diffusing Capacity (DLCO) tests to determine patients risk of developing pulmonary toxicities. Patients who develop pulmonary fibrosis should discontinue treatment immediately.

Secondary malignancies Long term use of lomustine is linked to secondary malignancies including acute leukemia and myelodysplasia, due to the drug's DNA alkylating properties.

… excerpt ends here. Continue reading the full article.

Illustrations

Worked examples

Example 1 — a first encounter with Lomustine

Start with the simplest possible case. Write down what Lomustine claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Lomustine before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Lomustine ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Lomustine

In research: Lomustine appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Lomustine in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Lomustine is common in secondary-school and first-year university syllabi. It links to neighbouring topics Alkylating antineoplastic agents, Cancer treatments, Chloroethyl compounds, so understanding it makes those chapters shorter.
In everyday life: Look for Lomustine outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

How to study Lomustine in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Lomustine means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Lomustine out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Lomustine in simple terms?

Lomustine (INN; abbreviated as CCNU; original brand name CeeNU, now marketed as Gleostine) is an alkylating nitrosourea compound used in chemotherapy. It is closely related to semustine and is in the same family as streptozotocin.

Why does Lomustine matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Lomustine?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Lomustine.